Buscar
Congreso SOLACI
HomeSOLACI-CACI'17Day 2

Day 2

Ver Categoría
Day 2

SOLACI CACI 2017 | Clinical evidence of TAVR in intermediate risk patients: Lessons from clinical trials

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Andreas...
solaci -
Ver más
Congenital cardiopathy

SOLACI CACI 2017 | Practical application of Quality Improvement projects: How to make it work

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dra....
solaci -
Ver más
Day 2

SOLACI 2017 | BRS: Present & Future

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Stephen...
solaci -
Ver más
Day 2

SOLACI CACI 2017 | BRS: Presente y Futuro

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Stephen...
solaci -
Ver más
Coronary disease

SOLACI CACI 2017 | CTO y CHIP Toolbox: Anatomía y Diseño de Guías Coronarias y MicroCatheters 101: Ingeniería para el Intervencionista”.

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Dimitrios...
solaci -
Ver más
Aorta

SOLACI CACI 2017 | Tipo II Endoleaks: Tratamiento obligatorio o un miedo infundado

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Hugo...
solaci -
Ver más
Day 2

SOLACI CACI | TAVI: Evidencia para pacientes de riesgo intermedio

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Oscar...
solaci -
Ver más
Day 2

SOLACI CACI 2017 | BRS at the crossroad: technological development to reduce complications

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Patrick...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

TCT 2024 | FAVOR III EUROPA

Dr. Carlos Fava - 0
The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

Dr. Carlos Fava - 0
This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Dr. Omar Tupayachi - 0
Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

Noticias Institucionales

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Arequipa Sessions 2024: Meet the International Guests

solaci - 0
The Arequipa Sessions 2024 is getting closer and closer. Meet the international guests who will share their knowledge for 2 days at a high-level...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad